ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
66.863,20
-0,32%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Johnson and Johnson (JNJ)

  7. Johnson and Johnson (JNJ) Notícias

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:JNJ
DataHoraFonteTítuloCódigoCompanhia
17/05/202412:21Edgar (US Regulatory)Form 8-K - Current reportNYSE:JNJJohnson and Johnson
17/05/202408:36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:JNJJohnson and Johnson
16/05/202417:16Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JNJJohnson and Johnson
16/05/202408:30Business WireJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentNYSE:JNJJohnson and Johnson
14/05/202418:01Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:JNJJohnson and Johnson
14/05/202408:26IH Market NewsWalmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More NewsNYSE:JNJJohnson and Johnson
14/05/202407:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:JNJJohnson and Johnson
10/05/202418:14Edgar (US Regulatory)Form 13F-HR - Quarterly report filed by institutional managers, HoldingsNYSE:JNJJohnson and Johnson
08/05/202417:30Business WireJohnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
06/05/202417:05GlobeNewswire Inc.Shockwave Medical Reports First Quarter 2024 Financial ResultsNYSE:JNJJohnson and Johnson
01/05/202407:30Business WireJohnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationNYSE:JNJJohnson and Johnson
22/04/202417:30Business WireJohnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)NYSE:JNJJohnson and Johnson
19/04/202408:31IH Market NewsParamount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and MoreNYSE:JNJJohnson and Johnson
17/04/202407:59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202417:33IH Market NewsU.S. Stocks Finish Lackluster Session Narrowly MixedNYSE:JNJJohnson and Johnson
16/04/202411:46Business WireCORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
16/04/202410:52IH Market NewsJ&J’s Q1 2024 sales rise 2.3% to $21.4 billionNYSE:JNJJohnson and Johnson
16/04/202410:09IH Market NewsDow Looks To Snap Six-Day Losing Streak As UnitedHealth SurgesNYSE:JNJJohnson and Johnson
16/04/202408:19IH Market NewsU.S. Index Futures Signal Mixed Trading, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202408:18IH Market NewsEricsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More NewsNYSE:JNJJohnson and Johnson
16/04/202407:25Business WireJohnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%NYSE:JNJJohnson and Johnson
16/04/202407:20Business WireJohnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
15/04/202417:38IH Market NewsU.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales DataNYSE:JNJJohnson and Johnson
08/04/202419:06Business WireJohnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
06/04/202400:21PR Newswire (US)CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of TherapyNYSE:JNJJohnson and Johnson
05/04/202415:55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.NYSE:JNJJohnson and Johnson
05/04/202408:38IH Market NewsApple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More UpdatesNYSE:JNJJohnson and Johnson
05/04/202407:31Business WireJohnson & Johnson to Acquire Shockwave MedicalNYSE:JNJJohnson and Johnson
04/04/202419:01Business WireJohnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment CorporationNYSE:JNJJohnson and Johnson
02/04/202417:30Business WireJohnson & Johnson to Participate in the BofA Securities Health Care ConferenceNYSE:JNJJohnson and Johnson
 Apresentando as notícias mais relevantes sobre:NYSE:JNJ

Seu Histórico Recente

ASX
FNPNA
ASX
AMPKOT
BIT
F08321
Vontobel Financial Produ...
NASDAQ
SLVO
Credit Suisse X Links Si...
COIN
XPLAUSD
XPLA
LSE
CCUA
Ubs Cmci Carry
NASDAQ
MVIR
MULTIVIR INC.
NASDAQ
ESSC
East Stone Acquisition
COIN
HMCUSD
BIT
F18196
Vontobel Financial Produ...
GATE
SFUNDUSDT
SeedifyFund
NASDAQ
ABAHUXX
Morgan Stanley Bank Na C...
UNSW
TTTETH
Tapcoin
COIN
KDAUST
Kadena
COIN
BETRAEUR
GATE
CREUSDT
CarryToken
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados